Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines

Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasceAuayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Maoko Naganuma, Mary A. Dwyer

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations

Abstract

These NCCN Guidelines Insights summarize several key updates to the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas (NHL) and describe the clinical evidence supporting the updates. The featured updates include changes to the recommendations for treatment options in patients with chronic lymphocytic leukemia (including in elderly or frail patients and patients with poor-risk cytogenetics), guidance surrounding surveillance imaging for follow-up of patients with NHL, and the addition of first-line consolidation options for patients with mantle cell lymphoma.

Original languageEnglish (US)
Pages (from-to)1487-1498
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2012

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this